carmustine and isoxazoles

carmustine has been researched along with isoxazoles in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evans, RG; Kimler, BF; Liu, C; Morantz, RA1
Beattie, BJ; Blasberg, RG; Malkin, MG; Thiessen, B; Vlassenko, AG1
Cherrington, JM; Kabbinavar, F; Mann, E; Schwartz, DP; Shawver, LK; Slamon, DJ; Strawn, LM1
Cho, E; Choi, K; Khosla, C; Omary, B; Piper, JL; Rich, KM; Siegel, M; Strnad, P; Yuan, L1
Choi, K; Jackson, EN; Khosla, C; Miller, CR; Piwnica-Worms, D; Rich, KM; Siegel, M; Yuan, L1

Other Studies

5 other study(ies) available for carmustine and isoxazoles

ArticleYear
Intracerebral chemotherapy in the 9L rat brain tumor model.
    Journal of neuro-oncology, 1992, Volume: 14, Issue:3

    Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Aziridines; Benzoquinones; Bleomycin; Brain Neoplasms; Carmustine; Cisplatin; Injections, Intralesional; Injections, Intraperitoneal; Isoxazoles; Male; Neoplasm Transplantation; Rats; Rats, Inbred F344

1992
Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
    Journal of neuro-oncology, 2000, Volume: 46, Issue:3

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biological Transport, Active; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Disease-Free Survival; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Glucose; Humans; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet-Derived Growth Factor; Prognosis; Signal Transduction; Supratentorial Neoplasms; Tomography, Emission-Computed; Treatment Outcome

2000
Effects of SU101 in combination with cytotoxic agents on the growth of subcutaneous tumor xenografts.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:7

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cell Division; Cell Survival; Cisplatin; Etoposide; Glioblastoma; Head and Neck Neoplasms; Humans; Isoxazoles; Leflunomide; Lung Neoplasms; Mice; Mice, Nude; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2000
Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2.
    Chemistry & biology, 2005, Volume: 12, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biological Availability; Carmustine; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Glioblastoma; GTP-Binding Proteins; Intestine, Small; Isoxazoles; Mice; Mice, Inbred C3H; Microscopy, Confocal; Protein Glutamine gamma Glutamyltransferase 2; Structure-Activity Relationship; Transglutaminases

2005
Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
    Oncogene, 2007, Apr-19, Volume: 26, Issue:18

    Topics: Animals; Brain; Brain Neoplasms; Carmustine; Enzyme Inhibitors; Extracellular Matrix; Female; Fibronectins; Fluorescent Antibody Technique; Glioblastoma; GTP-Binding Proteins; Humans; Isoxazoles; Mice; Mice, Inbred BALB C; Protein Glutamine gamma Glutamyltransferase 2; RNA, Small Interfering; Survival Rate; Transglutaminases; Tumor Cells, Cultured

2007